VIROMED
ViroMed is a leading biotechnology company. The company works on DNA and protein-based therapeutics for various life-threatening diseases, along with herbal-based medicines, and nutraceuticals. ViroMed has five main products in its pipeline targeting cardiovascular disease, cancer, and immune-related disorder, with clinical trials in the US, Korea, and China. The company has established partnerships with global firms including Johnson & Johnson (Biologics Delivery Systems Group of Cordis Corp., USA), SBI Biotech (Japan), and Green Cross (Korea). The company also conducts preclinical developmental studies in the aspects of toxicology, efficacy and pharmacokinetics. Phase I and II clinical studies are also carried out
VIROMED
Industry:
Biotechnology Therapeutics
Address:
Seoul, Seoul-t'ukpyolsi, South Korea
Country:
South Korea
Website Url:
http://www.viromed21.com
Status:
Closed
Contact:
+82-2-2102-7200
Technology used in webpage:
Domain Not Resolving
Similar Organizations
AITbiotech
AITbiotech is a leading biotechnology company
InBios
InBios is a leading biotechnology company
TikoMed
TikoMed is a biotechnology company.
More informations about "ViroMed"
Viromed, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
ABSTRACT In a general population survey in the United States, the prevalence of antiviral-agent-resistant herpes simplex virus was very low among more than 1,000 isolates from individuals …See details»
ViroMed - Crunchbase Company Profile & Funding
ViroMed is a leading biotechnology company. The company works on DNA and protein-based therapeutics for various life-threatening diseases, along with herbal-based medicines, and …See details»
Organization | ViroMed
Organization Overview. First Clinical Trial. 2007 NCT01422772. First Marketed Drug. None First NDA Approval. None Last Known Activity. 2018 Timeline < Back; View all... NOW. Now; Active …See details»
Viromed, Inc. (Viromed, Inc.) - 药物管线_专利_临床试验_投融营收_ …
ABSTRACT In a general population survey in the United States, the prevalence of antiviral-agent-resistant herpes simplex virus was very low among more than 1,000 isolates from individuals …See details»
Viromed, Inc.: Drug pipelines, Patents, Clinical trials - Synapse
Explore Viromed, Inc. with its drug pipeline, therapeutic area, technology platform, 1 clinical trial, 1 news.See details»
VIROMED CO., LTD. - Korea Israel Business Network Portal - KOIL Biz
ViroMed Co., Ltd. (KOSDAQ, 084990) is a leading biotechnology company located in Seoul, Korea with a US presence in Atlanta. The company has two main areas of focus: DNA/protein …See details»
ViroMed Receives US FDA Approval of Phase II Trial for VM202
Jul 21, 2009 · SEOUL, KOREA, Mar. 10 – ViroMed Co., Ltd. (KOSDAQ: 084990) today announced that VM202-PAD, the company’s proprietary DNA medicine for the treatment of …See details»
FDA Approves Initiation Of ViroMed's VM202 For Phase III
Sep 1, 2015 · ViroMed is developing new and innovative biopharmaceuticals for the treatment of currently untreatable diseases. VM202 has been developed by ViroMed using proprietary …See details»
ViroMed Laboratories - Crunchbase Company Profile & Funding
ViroMed Laboratories, a member of LabCorp's Specialty Testing Group, is an FDA-registered laboratory that provides infectious disease testing in support of our human cells, tissues and …See details»
Takeover of terraplasma medical GmbH by the Viromed Group
Sep 12, 2021 · Terraplasma GmbH, a spin-off of the Max Planck Institute (MPI) for extraterrestrial physics, will continue to be involved in terraplasma medical as a partner in order to continue …See details»
FDA grants Fast Track designation for VM202 to treat patients with …
May 17, 2016 · VM BioPharma, the US unit of South Korean biopharmaceutical company ViroMed, has secured fast track designation from the US Food and Drug Administration (FDA) …See details»
ViroMed Secures DNA Production Facility in the US - PR Newswire
Aug 20, 2018 · VM BioPharma is the US division of ViroMed Co., Ltd. which develops new and innovative biopharmaceuticals based upon its multiple proprietary scientific platform …See details»
ViroMed eyes global market entry with ‘revolutionary’ gene ... - KBR
Oct 19, 2017 · ViroMed is making more progress with its gene therapy, having registered the drug’s compound “donaperminogene seltoplasmid” with the World Health Organization and in …See details»
Donor Testing | ViroMed
ViroMed Laboratories provides infectious disease testing in support of our human cells, tissues and cellular and tissue-based products HCT donor clients.See details»
ViroMed's Donor Testing - Labcorp
ViroMed offers reproductive donor testing, tissue and eye bank testing, bone marrow and stem cell testing, core blood testing, and blood testing.See details»
ViroMed : US FDA Approves Initiation of ViroMed's VM202 for …
Sep 1, 2015 · ViroMed Co., Ltd. (084990:KS, KOSDAQ) today announced that the company has received an approval from the US FDA to launch a pivotal Phase III clinical trial utilizing …See details»
US FDA Approves Initiation of ViroMed's VM202 for Phase III …
Sep 1, 2015 · ATLANTA-- ( BUSINESS WIRE )-- ViroMed Co., Ltd. (084990:KS, KOSDAQ) today announced that the company has received an approval from the US FDA to launch a pivotal …See details»
Physicians Committee for Responsible Medicine - Wikipedia
The Physicians Committee for Responsible Medicine (PCRM) is a non-profit research and advocacy organization based in Washington, D.C. According to Charity Navigator, the …See details»
Viromed, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
Sign Up for Free. Last update 11 Jul 2024See details»
7 Organizational Structure Types (With Examples) – Forbes Advisor
May 29, 2024 · What Is an Organizational Structure? Every company needs an organizational structure—whether they realize it or not. The organizational structure is how the company …See details»